by impact | Nov 7, 2025 | Members blog
High Alert Trend Report: G-Type Substances Over the past six months, there has been a noticeable increase in the use of G-type substances (GBL, GHB, 1,4-BD) in New Zealand. Reports show higher doses and more frequent use, leading to increased harm and withdrawal...
by impact | Nov 7, 2025 | Uncategorised
Workplace Alcohol Testing During COVID-19 Workplace Alcohol Testing During COVID-19COVID-19 has had enormous impact on many businesses right across Australia, and in this series we will be looking at some of the many changes and new risks that have dramatically...
by impact | Nov 7, 2025 | General
Executive Market – A Potential New Market for Workplace Drug and Alcohol Testing Part of the WDTA’s charter is to help the industry grow beyond its current focus on safety-sensitive groups. The WDTA is collaborating with various organisations to promote the idea that...
by impact | Nov 7, 2025 | Uncategorised
Revision of AS/NZS 4308:2008 update Technical Committee 039 has been assembled under the Standards Australia and Standards New Zealand charter, to review Standard AS/NZS 4308-2008, Procedures for specimen collection and the detection and quantification of drugs of...
by impact | Feb 27, 2025 | General
Update on the Recent Webinar: Medicinal Cannabis in the Workplace I wanted to share a quick update from the recent webinar hosted by Construction Health and Safety New Zealand, in collaboration with the NZ Drug Foundation, Māori and Pacifica trades, and supported by...
